The director of preventive cardiology at the University of Michigan, says the medications are a promising option for many ...
For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been ...
With GLP-1 agonists slated to become the best-selling drugs in 2024, the biopharma industry is already pivoting to explore ...
Zepbound, a popular weight loss drug from Eli Lilly, may help people with sleep apnea. Based on recent findings, Eli Lilly ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an ...
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF ...
Pricing: Weight loss medications can cost as low as $199 per monthly (compound Semaglutide), or as much as $1,000 per month ...
Less than half of large employers currently cover the new generation of obesity drugs, but an additional 18% say they’re considering adding them amid surging interest. Nov. 11, 2023 In some ...
It’s clear that these drugs actually work, helping people with obesity lose far more weight ... The lack of supply, poor insurance coverage, and high list prices (over $1,000 a month without ...
Weight loss surgeries, GLP-1 drugs such as Wegovy, and lifestyle changes may all be able to boost brain health, though research varies. Most people know that obesity is linked to chronic disease ...
Suicide Risk-Obesity Drugs FILE - The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Drug regulators in Europe have found no evidence that popular diabetes and weight-loss ...
Visiongain has published a new report entitled Anti-obesity Drugs Market Report 2024-2034: Forecasts by Drug Type (Prescription, OTC), by Mechanism of Action (Glucagon Like Peptide GLP-1 Agonists ...